Background: We all know that the survival of the burn victims has increased due to the advances of the treatment in the critical phase. Because of that, the number of patients who shows sequels also increased. The objective of the present study is to measure the improvement in the quality of the lifetime of the patients with hypertrophic scars as result of burn or graft skin reducing, that way, the stigma caused by these scars. Many approaches have been done in order to prevent and treat pathological scars, frequently without success to some patients because the method or because of the difficulty of keeping the patient attached to the treatment. Method: Forty-six patients, 20 men and 26 women, have used 0.1% topic tamoxifen for a period of 4 to 12 months. Weekly evaluations were done during the first month and afterwards monthly, until a year. Photographs were taken after 6 months and a year. Results: Thirty-eight (82.6%) patients told that the improved in the first two weeks of treatment; 93.48% of the patients told that the scar height was reduced. In this study, we used tamoxifen citrate, an antineoplasic drug, to reduce the height of hypertrophic scars of burn marked patients. Conclusion: The results encouraged us to continue the treatment of scars with topic house use of tamoxifen.
Keywords: Burns. Keloid. Tamoxifen. Cicatrix hypertrophic